Daewoong Pharma (069620)

Currency in KRW
103,600
-4,900(-4.52%)
Closed·
Advertisement
Trading near 52-week Low
069620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
102,200109,900
52 wk Range
102,200199,400
Key Statistics
Bid/Ask
104,000.00 / 104,300.00
Prev. Close
108,500
Open
107,500
Day's Range
102,200-109,900
52 wk Range
102,200-199,400
Volume
29.24K
Average Volume (3m)
26.07K
1-Year Change
-21.6931%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
069620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
202,000
Upside
+94.98%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Daewoong Pharma News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 202,000
(+94.98% Upside)

Earnings

Latest Release
14/08/2026
EPS / Forecast
2,900.00 / --
Revenue / Forecast
447.65B / 390.72B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 16,988.64%
Dividend Yield
0.55%
Industry Median 1.22%
Annualised payout
600.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 069620 to Peers and Sector

Metrics to compare
069620
Peers
Sector
Relationship
P/E Ratio
6.1x7.3x−0.3x
PEG Ratio
0.040.030.00
Price/Book
1.1x0.9x2.6x
Price / LTM Sales
0.7x0.6x3.0x
Upside (Analyst Target)
86.2%57.7%59.8%
Fair Value Upside
Unlock35.3%7.1%Unlock

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Employees
1893

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
959.50K8.34%104.11B
Other Institutional Investors
9.38M81.53%1.02T
Public Companies & Retail Investors
1.17M10.13%126.51B
Total
11.51M100.00%1.25T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Daewoong Co., Ltd.52.65%6,058,200657,314,700
National Pension Service10.02%1,153,208125,123,068

People Also Watch

9,600
034230
-2.04%
95,100
005300
-0.21%
8,470
003850
-1.63%
92,400
000640
-0.65%
212,500
000250
-12.73%

FAQ

What Is the Daewoong Pharma (Seoul: 069620) Share Price Today?

The Daewoong Pharma stock price today is 103,600 KRW.

What Stock Exchange Does Daewoong Pharma (069620) Trade On?

Daewoong Pharma is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Daewoong Pharma?

The stock symbol (also called a 'ticker') for Daewoong Pharma is "069620."

Does Daewoong Pharma Pay Dividends? What’s The Current 069620 Dividend Yield?

Yes, 069620 Pays Dividends to its Shareholders. The current Daewoong Pharma dividend yield is 0.55%.

What Is the Current Daewoong Pharma Market Capitalisation?

As of today, Daewoong Pharma (Seoul: 069620) market cap is 1.25T KRW.

What Is Daewoong Pharma's (069620) Earnings Per Share (TTM)?

The Daewoong Pharma EPS is currently 16,989 (Trailing Twelve Months).

When Is the Next Daewoong Pharma Earnings Date?

Daewoong Pharma's next earnings report will be released on 12/11/2026.

Is 069620 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Daewoong Pharma moving averages and other technical indicators, the daily buy/sell signal for 069620 stock is Strong Sell.

How Many Times Has Daewoong Pharma Stock Split?

Daewoong Pharma has split 6 times. (See the 069620 stock split history page for full effective split date and price information.)

How Many Employees Does Daewoong Pharma Have?

Daewoong Pharma has 1893 employees, based on their latest Companies House report.

What is the current trading status of Daewoong Pharma (Seoul: 069620)?

As of 12/10/2026, Daewoong Pharma (069620) is trading at a share price of 103,600 KRW, with a previous close of 108,500 KRW. The stock has fluctuated within a day range of 102,200 KRW to 109,900 KRW, while its 52-week range spans from 102,200 KRW to 199,400 KRW.

What Is Daewoong Pharma (069620) Price Target According to Analysts?

The average 12-month price target for Daewoong Pharma is 202,000 KRW, with a high estimate of 220000 KRW and a low estimate of 180000 KRW. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +94.98% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.